Risk of Intracerebral Hemorrhage in Patients With Cerebral Microbleeds Undergoing Endovascular Intervention | Zendy

Yannie Soo | Zendy; Deyond Y.W. Siu | Zendy; Jill Abrigo | Zendy; Simon C.H. Yu | Zendy; Nick Zhi Peng Ng | Zendy; Anil T. Ahuja | Zendy; Ka Sing Wong | Zendy; Thomas Leung | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk of Intracerebral Hemorrhage in Patients With Cerebral Microbleeds Undergoing Endovascular Intervention

Author(s) -

Yannie Soo,

Deyond Y.W. Siu,

Jill Abrigo,

Simon C.H. Yu,

Nick Zhi Peng Ng,

Anil T. Ahuja,

Ka Sing Wong,

Thomas Leung

Publication year - 2012

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.111.626853

Subject(s) - medicine , intracerebral hemorrhage , stroke (engine) , clopidogrel , aspirin , radiology , angioplasty , subarachnoid hemorrhage , mechanical engineering , engineering

Cerebral microbleeds (CMBs) on MRI gradient echo images are hemosiderin deposits, which may predict intracerebral hemorrhage (ICH). The risk of ICH in patients with CMBs could be exacerbated by the use of antithrombotics. The purpose of our study is to prospectively evaluate the risk of ICH in patients with ischemic stroke who receive dual antiplatelet therapy for endovascular intervention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research